| Nov 20 |
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
|
| Nov 18 |
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
|
| Nov 17 |
PAVmed Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 15 |
Q3 2024 PAVmed Inc Earnings Call
|
| Nov 15 |
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring
|
| Nov 14 |
PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript
|
| Nov 14 |
PAVmed Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 14 |
PAVmed Non-GAAP EPS of -$0.54 beats by $0.76, revenue of $0.99M misses by $0.1M
|
| Nov 14 |
PAVmed Provides Business Update and Third Quarter 2024 Financial Results
|
| Nov 13 |
PAVmed Q3 2024 Earnings Preview
|
